China-Italy Pharmaceutical event in Hangzhou, 3-4.11

The Hangzhou Investment Promotion Bureau, in collaboration with Livolsi&Partners and the Italian Chamber of Commerce in China (CCIC), is pleased to invite you to the upcoming Italy-China Cooperation Initiative, dedicated to the development of new business opportunities for the pharmaceutical industry of the future. The event will take place on November 3–4, 2026, in Hangzhou, Zhejiang Province, bringing together Italian and Chinese bio-pharmaceutical companies, institutions and industry stakeholders.

Why participate?

The initiative offers a valuable opportunity to explore concrete future prospects for industrial and commercial cooperation between Italy and China in the bio-pharmaceutical sector. Participants will have the opportunity to identify potential partnerships, exchange expertise and explore opportunities related to technology transfer, investment, R&D, supply chains and market access. The programme is designed to foster collaboration and create new synergies that can support business development in China, Italy and international markets.

The event will take place over two days: the first features institutional and business representatives while the second day will focus on company visits in Hangzhou and B2B meetings.

AGENDA

November 3 – Institutional Event

• 15:00–15:10 – Welcome remarks by the Municipal Government of Hangzhou
• 15:10–15:20 – Institutional greetings
• 15:20–15:35 – Investment opportunities in Hangzhou's bio-pharmaceutical sector
• 15:35–15:50 – Overview of the Italian pharmaceutical market and key requirements for Italy-China cooperation by Alberto Conforti, Head of International Development at Livolsi&Partners
• 15:50–16:00 – Presentation of the CCIC Healthcare Working Group by Elena Barboni,BD Director of Flamma S.p.A. and Coordinator of CCIC HCWG
• 16:00–16:10 – Italy-China cooperation in APIs by Pierfrancesco Morosini, President at Aschimfarma (online)
• 16:10–16:30 – Keynote Presentation The Integration of Innovation between Multinational Corporations and China by Boston Consulting Group
• 16:30–16:40 – Italian company case study by Yu Jintao, General Manager of Copan Medical Shanghai Co.
• 16:40–17:00 – IT+BT integration and AI-enabled new drug development by Cao Ji, Professor at the College of Pharmaceutical Sciences, Zhejiang University and Executive Vice Director of Zhejiang University Institute of Intelligent Innovative Pharmaceuticals.
• 17:00–17:10 – Case study on internationalization projects by Tigermed
• 17:10–17:20 – Financial services supporting cooperation projects by Bank of Communications Zhejiang Branch
• 17:20–17:30 – Aschimfarma MOU signing ceremony
• 17:30–19:00 – Institutional welcome dinner
• 19:30 – Light show at the Urban Balcony

November 4 – B2B Meetings & Company Visits

• 09:30–10:30 – Visit to Hangzhou Biopharma Town and visit Hangzhou Institute of Medicine Chinese Academy of Sciences
• 10:30–11:00 – Chinese Enterprise Investment Institution Sharing by HeDa Fund
• 11:00-11:30 - Italian enterprise representatives share their experiences (2-3 companies)
• 11:30–12:00 – Targeted B2B meetings between Italian and Hangzhou-based companies
• 12:00–13:30 – Business lunch
• 14:00–16:00 – Visits to leading bio-pharmaceutical companies in Hangzhou: Betta pharma
• 16:00 – Closing remarks and departure arrangements

Event details

Date: Tuesday, November 3rd, 2026 – Wednesday, November 4th, 2026

Target:The event is open only to CCIC Members and pharmaceutical and medical devices companies. The confirmation is subject to prior approval.

Format: offline

Venue: 杭州瑞丽江河汇酒店 SORL Hotel Hangzhou

Address: 杭州市上城区三新路9号 No. 9 Sanxin Road, Shangcheng District, Hangzhou

Language: Chinese and English

The participation is free of charge, and it includes accommodation and meals in Hangzhou.



For more information contact us at: w.chen@cameraitacina.com